探索干预对刺激性肠综合征患者心理症状的影响:一项随机对照研究
Diksha Devi1, Sandeep Bhattacharya1, Sunita Tiwari2
1Department of Physiology, King George's Medical University, Lucknow, Uttar Pradesh, India.
International journal of yoga
|May 14, 2025
概括
可以显著降低患者的刺激性肠综合征 (IBS) 严重程度和心理困扰. 这项研究发现,与传统治疗相结合,可以改善IBS症状和幸福感.
科学领域:
- 胃肠病学 胃肠病学
- 综合医学是一个整体的医学.
- 精神病体医学是一种精神病体医学.
背景情况:
- 刺激性肠综合征 (IBS) 影响全球11-15%,导致显著的生活质量下降和相关的心理痛苦.
- 作为一种补充疗法,用于管理IBS症状并改善患者的福祉.
研究的目的:
- 评估作为接受常规治疗的刺激性肠综合征 (IBS) 患者的辅助疗法的疗效.
- 为了比较接受加常规治疗和仅接受常规治疗的IBS患者之间的结果.
主要方法:
- 一项随机对照试验,涉及165名通过罗马规则IV标准诊断的IBS患者.
- 参与者被分配到干预组 (+常规治疗,n=85) 或对照组 (仅常规治疗,n=80).
- 干预在三个月内每周进行五次,心理和IBS严重程度得分在干预前和后进行评估.
主要成果:
- 与对照组相比,干预组的体重,体重指数,IBS严重程度,心理压力和焦虑分数显著降低.
- 具体而言,在组中,IBS严重性得分显著下降 (P < 0.01),而在对照组中保持不变.
- 在干预后的组中观察到压力 (P < 0.05) 和焦虑 (P < 0.01) 的显著减少.
结论:
- ,当与传统的医疗治疗相结合时,对刺激性肠综合征 (IBS) 管理产生了积极的影响.
- 这些发现支持建议作为IBS患者有益的补充疗法,以缓解症状并改善心理健康.
相关概念视频
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
125
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
125
01:17Irritable Bowel Syndrome I: Introduction
210
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
210
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
101
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
101
01:17Drugs for Treatment of Diarrhea-Predominant IBS
126
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
126
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
259
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
259
01:21Drugs for Treatment of Constipation-Predominant IBS
117
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
117